Physician
Matthew Wade Floersch, M.D.
According to 2025 Medicare claims, Matthew Floersch, M.D. (NPI: 1114993698) practices internal medicine in the Manhattan, KS market, with the plurality of this provider's patient population coming from Riley, KS. This provider's primary affiliated billing organization is CENTERPOINTE PHYSICIANS PA (NPI: 1316439086; TIN: 830699289) and primary practice location at 66502-4462. Floersch is affiliated with the NPG Health Collaborative LLC (ACO ID: A3287), Aledade 38 KS CHC MSSP Enhanced (ACO ID: A4546), and Vytalize Health KS 25 LLC (ACO ID: A5671), participating under the MSSP model.
Floersch's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 914 traditional Medicare patients, billed 10,665 HCPCS/CPT codes, and received $254,533 in Medicare payments. The top billing code was G0439 (Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit). Part D data shows 14,197 prescription claims across 641 beneficiaries totaling $904,291 in drug costs, led by Eliquis (Apixaban). DME data shows 472 claims. Open Payments data shows 6 records totaling $107. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.
Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $134,334 to $254,533. Similarly, Part D prescription costs have risen steadily, from $530,868 to $904,291. In contrast, DME billing represents a smaller volume and did not follow a clear longitudinal pattern.